PC_060 Acceptability, Tolerability, and High-Resolution Anoscopy Findings from a Phase I Dose-Escalation Trial of Anal Curcumin in Persons Living with HIV with High-Grade Anal Dysplasia
K. Lymon, M.G. Tadros, N. Kaonga, N. Kamili, C. Mehta, C. Xiao, V. Velu, L. Flowers
Emory University, Atlanta, États-Unis
PC_036 Awareness and Knowledge about Cervical Cancer Prevention and HPV Vaccination -Survey among students at the University of Lahore, Pakistan-
M. Wieneke
Universität Oldenburg, Oldenburg, Allemagne
PC_061 Long-term Efficacy and Safety of Hexaminolevulinate Photodynamic Therapy (HAL-PDT) in CIN2 Patients: Results from a Phase III Randomized Controlled Trial
L. Zhu (1), P. Hillemanns (2), F. Chen (1), H. Ruan (3), Z. Novak (4), L. Woelber (5), L. Sui (6), B. Li (7), J. Lang (1)
(1) Peking Union Medical College Hospital, Beijing, Chine, (2) Medizinische Hochschule Hannover, Hannover, Allemagne, (3) Nanjing Maternity And Child Health Hospital, Nanjing, Chine, (4) Aranyklinika Gynaecology, Budapest, Hongrie, (5) University Medical Centre Hamburg-Eppendorf, Hamburg, Allemagne, (6) Obstetrics & Gynecology Hospital Of Fudan University, Shanghai, Chine, (7) Asieris Pharmaceuticals, Shanghai, Chine
PC_038 Condyloma lata: an important gynecological finding for the diagnosis of secondary syphilis.
G. Marchetti, A. Bittencourt Campaner, D. Pereira Ayres Netto
Irmandade Da Santa Casa De Misericórdia De São Paulo, São Paulo, Brésil
PC_062 Look and LEEP: A 5-year audit of the colposcopy clinic at Groote Schuur Hospital. Cape Town. South Africa
N. Mbatani, M. Whelpton
University Of Cape Town, Cape Town, Afrique du Sud
PC_015 Sustaining and scaling HPV-based cervical screening in hospital-based antenatal care: an implementation evaluation
J. Dixon (1), A. Machado Colling (1), C. Nightingale (1), D. Rolnik (2), D. Hawkes (3), M. Saville (3), A. Bastable (4), M. Smith (5), J. Brotherton (1)
(1) The University Of Melbourne, Melbourne, Australie, (2) Monash University, Melbourne, Australie, (3) The Australian Centre For The Prevention Of Cervical Cancer, Melbourne, Australie, (4) Cancer Council Victoria, Melbourne, Australie, (5) The University Of Sydney, Sydney, Australie
PC_016 Determining the genetic risk for cervical cancer
A. Minaeva (1), M. Vinokurov (2), G. Leshkina (2), K. Mironov (2), A. Efimova (1)
(1) Medical Institute, Peoples’ Friendship University Of Russia Named After Patrice Lumumba (rudn University); Fomin Clinic, Moscow, Russie (Fédération de), (2) Central Research Institute For Epidemiology, Federal Service For Surveillance On Consumer Rights Protection And Human Wellbeing, Moscow, Russia, Moscow, Russie (Fédération de)
PC_017 Determinants of Non-Participation in Cervical Cancer Screening by Human Papilloma Virus Self-Sampling among Urban Women in Mumbai, India.
S. Pimple (1), D. Thiruvengadam (2), G. Mishra (3), A. Maheshwari (4), S. Biswas (4), K. Prasad (5)
(1) Head Of The Department Of Preventive Oncology, Tmh, Mumbai, Mumbai, Inde, (2) Fellow 2, Preventive Oncology, Tmh, Mumbai, Mumbai, Inde, (3) Professor, Department Of Preventive Oncology, Tata Memorial Hospital, Mumbai, Mumbai, Inde, (4) Head Of Department Of Gynec-Oncology Tmh, Mumbai, Mumbai, Inde, (5) Director, Manipal School Of Information Sciences, Mahe, Manipal, Inde
PC_019 Psychological Parameters in Individuals with a Positive HPV Test and Normal Cytology (Pap I or IIa) Compared to Individuals with a Negative or Unknown HPV Status (HAPPI study)
W. Reents (1), A. Hildebrandt (1), M. Schild-Suhren (2), A. Lindig (1)
(1) Department Of Psychology, Faculty Of Medicine And Health Sciences, University Medicine Oldenburg, Carl Von Ossietzky Universität Oldenburg, Oldenburg, Allemagne, (2) Cervical Dysplasia Unit, Department Of Gynecology, Faculty Of Medicine And Health Sciences, University Medicine Oldenburg, Klinikum Oldenburg, Oldenburg, Allemagne
PC_020 Multiple Dimensions of Social Vulnerability and Cervical Cancer Screening Uptake: A cohort Study
J. Haury (1), S. Crequit (2), G. Canlorbe (1), B. Renevier (2)
(1) Pitié Salpêtrière, Paris, France, (2) Hôpital Andre Gregoire, Montreuil, France
